Orthopaedic Oncology Market Growth and Forecast 2015-2025

Global Orthopaedic
Oncology Market
Share, Global Trends,
Analysis, Research, Report,
Opportunities,
Segmentation and Forecast,
2016 – 2026
Future Market Insights
www.futuremarketinsights.com
sales@futuremarketinsights.com

Report Description
Orthopedic oncology accounts for a small proportion in orthopedics. Orthopedic oncology is a
condition that arises due to the formation of benign and malignant tumors in bones and
connective soft tissues. It also includes the diagnosis and treatment of patients with metastatic
carcinomato the skeleton. Bone and soft tissue tumors are quite rare and sometimes require
reconstructive surgery. Soft tissue sarcomas are more common than bone sarcomas. For 2016,
the American Cancer Society estimates about 3,300 new cases for cancer of the bones and joints
and 12,310 new cases for soft tissue sarcomas. There are three main types of bone cancers,
osteosarcoma, which arises most often in the growing ends of long bones, chondrosarcoma,
which develops in the metaphysis and Ewing’s sarcoma. Malignant bone tumors also referred to
as chondrosarcoma are more prevalent in adults than other form of cancers and remains a
challenging tumor to diagnose and treat. Treatment with chemotherapy and radiotherapy do
not remain the preferred choice of treatment in treating such type of tumor as clinical studies
demonstrate no substantial improvements in the survival rate of the patients. Therefore,
adequate surgical resection is the mainstay of treatment in case of chondrosarcoma. As
estimated by the American Cancer Society, chondrosarcomas is more prevalent with 40% of
cases developing in adults whereas less than 5% of cases occur in patients younger than 20.
Radiofrequency ablation has become the standard and most preferred choice of treatment in
case of osteoid osteoma, a benign bone tumor that arises from osteoblasts. However studies
demonstrates its expanded application in palliative treatment of patients with painful bone
metastasis.

Report Description
The ability to perform less invasive procedures often allows more efficient, less painful, and
more cost-effective patient care. In addition, minimally invasive techniques such as kyphoplasty,
vertebroplasty, and acetabuloplasty may provide an alternative to major reconstructive surgery
for patients with metastatic disease.
Request Free Report Sample@ http://www.futuremarketinsights.com/reports/sample/rep-gb-
1523
Global Orthopaedic Oncology Market: Drivers & Restraints
Factors driving the global orthopedic oncology market includes rapidly ageing population with
increasing risk of developing cancer. Patients who had prior high-dose external radiation therapy
or treatment with anti-cancer drugs are at higher risk of developing osteosarcoma. However, a
small number of bone cancers also develop due to heredity defects of bones and people with
metal implants, which doctors sometimes use to repair fractures, are more likely to develop
osteosarcoma. In case of soft tissue sarcoma adults with heredity disorders such as
retinoblastoma, tuberous sclerosis, werner syndrome etc are at higher side of developing this
type of cancer.
High cost associated with the treatment for musculoskeletal oncology diseases and lack of
awareness regarding the effective treatment therapies are some of the factors which restraint
the market growth in the near future

Report Description
Global Orthopaedic Oncology Market: Segmentation
Orthopedic Oncology market is segmented by treatment, by end user and geography:
By Treatment
• Surgery
• Amputation
• Limb Salvage Surgery
• Reconstructive Surgery
• Chemotherapy
• Radiation Therapy
• Targeted Therapy
By End User
• Multispecialty Hospitals
• Cancer Research Institutes
Visit For TOC@ http://www.futuremarketinsights.com/toc/rep-gb-1523
Global Orthopaedic Oncology Market: Overview
Rising prevalence of musculoskeletal disorders are expected to drive the demand for effective
treatment therapies for treatment of various cancers associated with bones and soft tissues. The
orthopaedic oncology market is expected to grow at a healthy pace attributed to rising
prevalence of cancer over the forecasted period.

Report Description
Global Orthopaedic Oncology Market: Region-wise Outlook
On the basis of region presence, thrombophilia treatment market is segmented into seven key
regions: North America, Latin America, and Eastern Europe, Western Europe, and Asia pacific
excluding japan, Japan, Middle East and Africa. Global market for Orthopediac oncology is
expected to be on a higher side in North America and Europe owing to increasing prevalence of
cancer and musculoskeletal related disorders. Asia pacific represents immense growth
opportunity for orthopedic oncology market attributed to rapidly aging population and rising
cancer incidence. In addition macroeconomic factors such as FDA approvals are also expected to
increase the adoption rate of devices in the developed countries.
Discussion With Analyst@ http://www.futuremarketinsights.com/askus/rep-gb-1523
Global Orthopaedic Oncology Market: Key Players
Some of the key market players in the orthopedic oncology market are Stryker Corporation,
Accentus Inc., Roche Diagnostics, Amgen Inc., Novartis AG, Biogen Idec, GlaxoSmithKline, Sanofi
S.A., and Pfizer Inc.

Customized
Research
Syndicated
Research
Investment
Research
Social Media
Research
Future Market Insights (FMI) is a premier provider of syndicated research reports, custom research reports, and consulting
services. We deliver a complete packaged solution, which combines current market intelligence, statistical anecdotes,
technology inputs, valuable growth insights, aerial view of the competitive framework, and future market trends.
We provide research services at a global as well as regional level; key regions include GCC, ASEAN, and BRIC.
Our offerings cover a broad spectrum of industries including Chemicals, Materials, Energy, Technology, Healthcare, and
Retail.
We have a global presence with delivery centers across India specializing in providing global research reports and country
research reports. FMI is headquartered out of London, U.K., with a state-of-the-art delivery center located in Pune, India.
We combine our knowledge and learning from every corner of the world to distill it to one thing – the perfect solution for
our client.
Research
Capabilities
• Customized Research
• Syndicated Research
• Investment Research
• Social Media Research
Subscription Information
Sector Coverage
For detailed subscription information please contact
Hari. T (Sr. Manager - Global Business Development)
T: +44 (0) 20 7692 8790 | D: +44 20 3287 4268
Email: hari.t@futuremarketinsights.com
• Automotive and Transportation
• Chemicals & Materials
• Electronics, Semiconductor, and ICT • Food and Beverages
• Retail and Consumer Products
• Services and Utilities
• Industrial Automation and Equipment • Energy, Mining, Oil, and
• Healthcare, Pharmaceuticals & Medical Devices Gas

Thank You!
To know more about us, please visit our website:
www.futuremarketinsights.com
For sales queries or new topics email us on:
sales@futuremarketinsights.com
For other queries contact:
Future Market Insights: 616 Corporate Way, Suite 2-9018,
Valley Cottage, NY 10989, United States
T: +1-347-918-3531 | D: +1-845-579-5705